Fig. 2From: Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysisComparison of incidence rates of chemotherapy-induced nausea and vomiting (CINV) following CDDP, 5-FU, and triple antiemetic therapy in patients treated with ramosetron (n = 44) and palonosetron (n = 66)Back to article page